Juno Therapeutics — Deal History & Benchmarks
Total Deals
2
Across 1 therapeutic area
Total Deal Value
$18B
Cumulative transaction value
Most Active Year
2018
2 deals closed
Primary TA
Hematology
100% of deal activity
Market Analysis
Juno Therapeutics has been involved in 2 transactions totaling $18B across Hematology. As a licensor (out-licensor), they have demonstrated an active acquisition strategy.
PRO
Full Benchmark Analysis
Complete deal term ranges, comparable transactions, and negotiation insights.
We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.
or
Unlock Everything — $299/mo Pro7-day money-back guarantee · Cancel anytime
Customize these benchmarks for your asset
Adjust phase, modality, competitive position, and 10+ other parameters.
Frequently Asked Questions
How many deals has Juno Therapeutics done?
Juno Therapeutics has completed 2 verified transactions tracked in our database, spanning from 2018 to 2018. These deals have a combined value of $18B.
PRO
Full Benchmark Analysis
Complete deal term ranges, comparable transactions, and negotiation insights.
We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.
or
Unlock Everything — $299/mo Pro7-day money-back guarantee · Cancel anytime
Ready to Calculate Your Deal Terms?
Get instant, customized benchmarks based on real market data from 600+ biopharma licensing deals.
Start Calculating